SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Raleigh, NC
Activity/Course #:
: 06.16.18PC

Cost:
: Free
Release/Start Date:
: Jun 16 2018
Expiration Date:
: Jun 16 2018
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.0 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, June 16, 2018
Hilton North Raleigh Midtown
3415 Wake Forest Road
Raleigh, NC 27609
919-872-2323
 
 
Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Complimentary self-parking is available at the hotel.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

At the conclusion of this program, participants should be able to:

 1. Describe the newer concepts in the pathophysiology of asthma and type 2 inflammation, and the implications of biologic therapies in the era of precision medicine; Determine the utility of simple biomarkers to identify patients who are candidates for targeted biologic therapies and appropriate referral; Discuss the impact of comorbid conditions on asthma control and the evidence-based approach to their treatment; Discuss the paradigms of multidisciplinary care in asthma, with an emphasis on patient and provider education, to improve adherence to inhalers and emerging biologic therapies in asthma

2. Recognize the pathogenesis of type 2 diabetes (T2DM) as a progressive, multi-defect disorder; Discuss the strengths and limitations of current guidelines for diabetes management; Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes; Examine data on current combination strategies to choose therapies that most effectively address a patient’s underlying pathophysiologic needs

3. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events

4. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression

5. Review and characterize the clinical features of atopic dermatitis (AD); Discuss the current immuno-pathophysiology of AD; Identify strategies for comprehensive treatment of atopic dermatitis in pediatric and adult populations; Update and position emerging topical therapies as well as up and coming targeted biologic agents as a new treatment category for AD

6. Identify and describe the clinical features of psoriatic skin and joint disease; Review and discuss associated comorbidities and emerging bio factors and their significance in the management of psoriatic disease; Discuss the expanding and dynamically changing treatment paradigm for psoriasis and its related disorders; Review and interpret up to date evidence-based clinical trial data and the latest treatments available for the management of psoriatic disease



Agenda *

 

7:30-8:00

  Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Jack Kravitz, MD
8:10-9:20  

The Role of Type 2 Inflammation in Severe Persistent Asthma: Integrating Biologic Therapy to Optimize Outcomes
Sandra G. Adams, MD, MS

9:20-10:30  

The Progression of Type 2 Diabetes: A Rational Approach for Long Term Disease Management
Javier Morales, MD, FACP, FACE

10:30-10:50   Break
10:50-12:00  

Safely Achieving Goals in Type 2 Diabetes (T2DM): The Role of Concentrated and Long-Acting Insulins
Javier Morales, MD, FACP, FACE

12:00-1:00

 

Lunch

1:00-2:10   Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data into Practice
Alexander Duarte, MD
2:10-3:20  

Atopic Dermatitis: New Insights, New Therapies
Paul Yamauchi, MD, Ph. D.

   3:20-3:30 Break
   3:30-4:40 

Confronting Psoriatic Disease: Putting New Tools to Work
Paul Yamauchi, MD, Ph. D.

  4:40-4:45 

Summary of Key Points and Closing Remarks
Jack Kravitz, MD

 
*Agenda subject to change.

Faculty

Sandra G. Adams, MD, MS
Professor, Division of Pulmonary Diseases and Critical Care Medicine
UT Health San Antonio
Staff Physician, The South Texas Veterans Health Care System
Founder, President
WipeDiseases Foundation
San Antonio, TX

Alexander Duarte, MD
Professor, Division of Pulmonary Critical Care & Sleep Medicine
Department of Internal Medicine
University of Texas Medical Branch
Galveston, TX

Jack Kravitz, MD
Family Practice - Geriatrics
Coral Springs, FL

Javier Morales, MD, FACP, FACE
Clinical Associate Professor of Medicine
Donald and Barbara Zucker School of Medicine At Hofstra/Northwell University
Vice President
Advanced Internal Medicine Group, P.C.
East Hills, NY

Paul S. Yamauchi, MD, Ph.D.
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Harbor-UCLA Medical Center Division of Dermatology
Adjunct Associate Professor John Wayne Cancer Institute
Dermatology Institute & Skin Care Center, Inc.
Clinical Science Institute
Santa Monica, CA

Planning Commitee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 Contact hour(s) of continuing education which includes 3.0 pharmacology hour(s).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., an educational grant from AstraZeneca Pharmaceuticals LP, an educational grant from Novo Nordisk Inc, an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals, and an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.